Diagnosis and therapy of Wilms' tumor;DER WILMS-TUMOR

Praxis

Volumn 85, Issue 23, 1996, Pages 753-761

  Graf, N ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

diagnosis; nephroblastoma; prognosis; treatment; Wilm's tumor

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; IFOSFAMIDE; VINCRISTINE;

CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL FEATURE; HUMAN; INCIDENCE; NEPHROBLASTOMA; NEUROPATHY; PATHOLOGY; PROGNOSIS; REVIEW;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CONTROLLED CLINICAL TRIALS; HUMANS; INFANT; KIDNEY NEOPLASMS; PROGNOSIS; PROSPECTIVE STUDIES; WILMS TUMOR;

EID: 0029948617     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Rance T. F.: Causes of lung hematodes of the kidneys. Med. Phys. J. 132, 19, 1814.
2. Wilms M.: Die Mischgeschwülste der Niere. Arthur Georgi, Leipzig, 1-90, 1899.
3. Haaf H. G., Kaatsch P., Michaelis J.: Jahresbericht 1992 des Deutschen Kinderkrebsregisters, Mainz.
4. Gutjahr P., Kaatsch P., Spaar H. J., Niethammer D., Göbel U., Henze G., Ludwig R., Kühl J., Erttmann R., Harms D., Hohenfellner R.: Klinik, Therapie und Prognose bei 373 Kindern mit Wilms-Tumoren - Ergebnisse der bundesweiten Studie 1980 bis 1988. Akt. Urol. 21, 132-141, 1990.
5. Miller R. W., Fraumeni J. R., Manning M. D.: Association of Wilms' tumor with aniridia, hemihypertrophy and other congenital anomalies. N. Engl. J. Med. 270, 922-927, 1964.
6. Bürger D., Feickert H. J., Mildenberger H.: Current status of nephroblastoma treatment. Monogr. Paediatr. 18, 224-242, 1986.
7. Breslow N. E., Norkool P. A., Olshan A., Evans A., D'Angio G.: Second malignant neoplasm in survivors of Wilms' tumor: a report from the national Wilms' tumor study. J. Natl. Cancer Inst. 80, 592-595, 1988.
8. Francke U., Holmes L. B., Atkins L., Riccardi V. M.: Aniridia-Wilms' tumor association: Evidence for specific deletion of 11p13. Cytogenet. Cell Genet. 24, 185-192, 1979.
9. Riccardi V. M., Sujyansky E., Smith A. C., Francke V: Chromosomal imbalance in the aniridia-Wilms' tumor association lip interstitial deletion. Pediatrics 61, 604-610, 1978.
10. Couillin P., Azoulay M., Henry I., Ravise N., Grisard M. C., Jeanpierre C., Barichard F., Metezeau P., Candelier J. J., Lewis W., van Heyningen V., Junien C.: Characterization of a panel of somatic cell hybrids for subregional mapping along 11p and within band 11p13. Hum. Genet. 82, 171-178, 1989.
11. Cowell J. K., Wadey R. B., Buckle B. B., Pritchard J.: The aniridia-Wilms' tumor association: molecular and genetic analysis of chromosome deletions on the short arm of chromosome 11. Hum. Genet.
12. HGM 10 Human Gene Mapping 10. 10th international workshop on human gene mapping. Cytogenet. Cell Genet. 51, Nos 1-4, 1989.
13. Van Heyningen A., Boyd P. A., Seawright A., Fletcher J. M, Fantes J. A., Buckton K. E., Spowart G., Porteous D. J, Hill R. E., Newton M. S., Hastie N. D.: Molecular analysis of chromosome 11 deletions in aniridia-Wilms' tumor syndrome. Proc. Natl. Acad. Sci. USA 82, 8592-8596, 1985.
14. Call K., Glaser T. M., Ito C. Y., Buckler A. J., Pelletier J., Haber D. A., Rose E. A., Kral A., Yeger H., Lewis W. H., Jones C. A., Housman D. E.: Isolation and characterization of a zinc finger polypeptide gene at human chromosome 11 Wilms' tumor locus. Cell 60, 509-520, 1990.
15. Gessler M., Poustka A., Cavenee W., Neve R. L., Orkin S. H., Bruns G. A. P.: Homozygous deletion in Wilms' tumor of a zinc-finger gene identified by chromosome jumping. Nature 343, 774-778, 1990.
16. Madden S. L., Cook D. M., Morris J. F., Gashler A., Sukhatme V. P., Rauscher F. J.: Transcriptional repression mediated by the WT1 Wilms' tumor gene product. Science 253, 1550-1553, 1991.
17. Rauscher F. J., Morris J. F., Tournay O. E., Cook D. M., Curran T.: Binding of the Wilms' tumor zinc finger protein to the EGR-1 consensus sequence. Science 250, 1259-1262, 1990.
18. Koufos A., Grundy P., Morgan K., Aleck K. A., Hadro T., Lampkin B. C., Kalbakji A., Cavenee W. K.: Familial Wiedemann-Beckwith syndrome and a second Wilms' tumor locus map to 11p15.5. Am. J. Hum. Genet. 44, 711-719, 1989.
19. Ping A. J., Reeve A. E., Law D. J., Young M. R., Boehnke M., Feinberg A. P.: Genetic linkage of Beckwith-Wiedemann syndrome to 11p15. Am. J. Hum. Genet. 44, 720-723, 1989.
20. Haber D. A., Buckler A. J., Glaser T., Call K. M., Pelletier J., Sohn R. L., Douglass E. C., Housman D. E.: An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor. Cell 61, 1257-1269, 1990.
21. Henry I., Grandjouan I., Couillin P., Barichard F., Huerre-Jeanpierre A., Glaser T., Philip T., Lenoir G., Chaussain J. L., Junien C.: Tumor-specific loss of 11p15.5 alleles in del 11p13 Wilms' tumor and in familial adrenocortical carcinoma. Proc. Natl. Acad. Sci. USA 86, 3247-3251, 1989.
22. Grundy P., Koufos A., Morgan K., Li F. P., Meadows A. T., Cavenee W. K.: Familial predisposition to Wilms' tumour does not map to the short arm of chromosome 11. Nature 336, 374-376, 1988.
23. Huff V., Compton D. A., Chao L. Y., Strong L. C., Geiser C. F., Saunders G. F.: Lack of linkage of familial Wilms' tumour to chromosomal band 11p13. Nature 336, 377-378, 1988.
24. Schwartz C. E., Haber D. E., Stanton V. P., Strong L. C., Skolnick M. H., Housman D. E.: Familial predisposition to Wilms' tumor does not segregate with the WT1 gene. Genomics 10, 27-930, 1991.
25. Schmidt D., Kramer A., Leuschner I., Weirich A., Ludwig R., Harms D.: Tumor regression in nephroblastoma after preoperative chemotherapy according to SIOP 9/GPO. Morphological features and relationship to prognosis. Med. Ped. Oncol. 20, A166, Seite 433, 1992.
26. Harms D., Schmidt D., Leuschner I.: Neue Aspekte der Nephroblastome (Wilms-Tumoren) und anderer metanephrogener Neoplasmen. Verh. Dtsch. Ges. Path. 73, 350-371, 1989.
27. Harms D.: Studienprotokoll der Nephroblastomstudie SIOP 93-01/GPOH. Seite 67-75. 1993.
28. Wilms' tumor trial and study S.I.O.P. VI. Committee Report, May 1988.
29. D'Angio G. J., Evans A., Breslow N., Beckwith B., Bishop H., Feigl P., Goodwin W., Leape L. L., Sinks L. F., Sutow W., Tefft M., Wolff J.: The treatment of Wilms' tumor. Results of the National Wilms Tumor Study. Cancer 38, 633-646, 1976.
30. D'Angio G. J., Evans A., Breslow N., Beckwith B., Bishop H., Farewell V., Goodwin W., Leape L., Palmer N., Sinks L., Sutow W., Tefft M., Wolff J.: The treatment of Wilms' tumor. Results of the Second National Wilms' Tumor Study. Cancer 47, 2302-2311, 1981.
31. D'Angio G. J., Breslow N., Beckwith B., Evans A., Baum E., DeLorimier A., Fernbach D., Hrabovsky E., Jones B., Kelalis P., Othersen B., Tefft M., Thomas P. R. M.: Treatment of Wilms' tumor. Results of the Third National Wilms' Tumor Study. Cancer 64, 349-360, 1989.
32. Lemerle J., Voute P. A., Tournade M. F., Delemarre J. F. M., Jereb B., Ahström L., Flammant R., Gerard-Marchant R.: Preoperative versus postoperative radiotherapy, single versus multiple courses of Actinomycin-D in the treatment of Wilms' tumor. Preliminary results of a controlled clinical trial conducted by the International Society of Paediatric Oncology (SIOP). Cancer 38, 647-654, 1976.
33. Lemerle J., Tournade M. F., Voute P. A.: Effectiveness of preoperative radiotherapy (POXRT) and/or chemotherapy (POC) in Wilms' tumor (WT). Proc. Ann. Meet. Am. Soc. Clin. Oncol. 22, C 294, 1981.
34. Lemerle J., Voute P. A., Tournade M. F., Rodary C., Delemarre J. F. M., Sarrazin D., Burgers J. - M. V., Sandstedt B., Mildenberger H., Carli M., Jereb B., Moormann-Voestermans C. G. M.: Effectiveness of preoperative chemotherapy in Wilms' tumor: Results of an International Society of Pediatric Oncology (SIOP) clinical trial. J. Clin. Oncol. 1, 604-609, 1983.
35. Tournade M. F., Com-Nougué C., Voûte P. A., Lemerle J., de Kraker J., Delemarre J. F. M., Burgers M., Habrand J. L., Moorman C. G. M., Bürger D., Rey A., Zucker J. M., Carli M., Jereb B., Bey P., Gauthier F., Sandstedt B.: Results of the sixth International Society of Pediatric Oncology Wilms' Tumor Trial and Study: A Risk-Adapted Therapeutic Approach in Wilms' Tumor. J. Clin. Oncol. 11, 1014-1023, 1993.
36. Tournade M. F., Ludwig R., Voute P., Lemerle J., Weirich A., Delemarre J., Gauthier F., Pötter R., Rey A., Habrand J. L., de Kraker J., Bürger D., Burgers M.: Preliminary report of the nephroblastoma clinical trial SIOP 9. Med. and Ped. Oncol. A 361, 1991.
37. Ritchey M., Panayotis P. K., Breslow N., Etzioni R., Evans I., Haase G. M., D'Angio G. J.: Surgical complications after nephrectomy for Wilms' tumor. Surg. Gynecol. Obstetr. 175, 507-514, 1992.
38. Beckwith J. B.: Histopathological aspects of renal tumors in children. In: Renal tumors: Proceedings of the First International Symposium on Kidney Tumors, Alan R. (ed.), Lissabon, New York, 1-14, 1982.
39. Ludwig R., Weirich A., Pötter R., Harms D., Bürger D., Michaelis J., Errtmann R., Weinel P., Haas R. J., Ritter J., Jakobi H.: Präoperative Chemotherapie des Nephroblastoms. Klin. Pädiatr. 204, 204-213, 1992.
40. Pein F., Tournade M. F., Bergeron C., Brunat-Mentigny M., Deville A., Gentet J. C., Plantaz D., Plouvier E., Zucker J. M.: Combination etoposid (VP 16) and Carboplatin (CBDCA) for resistant or relapsed Wilms' tumor (WT). A phase II study conducted by the French Society of Pediatric Oncology (SFOP). Proc. Ann. Meet Am. Soc. Clin. Oncol. 9 A, 1138, 1990.
41. Wilms' tumor trial and study S.I.O.P. VI. Committee Report, Juni 1994.
42. D'Angio G. J.: Unexpected toxicity encountered in the National Wilms' Tumor study. Cancer Treat. Rep. 71, 993, 1987.
43. Oberlin O., Tournade M. F., Daltroff G., Quintana E., Tron P. H., Chastagne P., Brunat-Mentigny M., Lutz P., Otten J., Jullien M.: Hepatic toxicity compatible with veinoocclusive disease (VOD) after actinomycin D in non-irradiated Wilms' tumors. Med. Ped. Oncol. 17, 317, 1989.
44. Raine J., Bowman A., Wallendszus K., Pritchard J.: Hepatopathy-Thrombocytopenia Syndrome - A complication of Dactinomycin therapy for Wilms' Tumor: A report from the United Kingdom Childrens Cancer Study Group. J. Clin. Oncol. 9, 268-273, 1991.
45. Ludwig R., Weirich A., Hofmann W. J., Waldherr R.: Veno-occlusive disease (VOD) as hepatotoxic side effect of the nephroblastoma SIOP-9 treatment protocol: preliminary results of the german group. Med. and Ped. Oncol. 20, 434, 1992.
46. Pfeil J., Niethard F. V., Oppermann H. C., Scheibel P., Willich E.: Strahlenschäden der Wirbelsäule nach Radiatio wegen eines Wilms' Tumors im Kleinkindesalter. Verlaufsuntersuchung bei 82 Kindern. Orthopäd. Praxis 22, 863-870, 1986.
47. Thomas P. R. M., Griffith K. D., Fineberg B. B., Perez C. A., Land V. J.: Late effects of Treatment for Wilms' Tumour. Int. J. Radiat. Oncol. Biol. Phys. 9, 651-657, 1983.
48. The National Wilms' Tumor Study Committee: Wilms' Tumor: Status Report, 1990. J. Clin. Oncol. 9, 877-887, 1991.